
Amended Trial: Lova Sun Describes Important Changes to the EA3231 Study for Patients With BRAF-Mutated Differentiated Thyroid Cancer
November 19, 2026
INTerpath-001 and Personalized mRNA Vaccination in Resected High-Risk Melanoma
November 19, 202635 Member Networks and Programs Receive Commendations in 2026 for Research Performance
35 Member Networks and Programs Receive Commendations in 2026 for Research Performance
Each year, the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) conducts an Institution Evaluation in which a subset of Principal Investigator (PI) Committee members and senior administrators meet to evaluate the performance of ECOG-ACRIN member networks and programs. The exceptional staff in the Membership Department facilitates the process—encompassing 1338 individual research institutions, comprising 123 research programs. Through this annual review, principal investigators and research personnel stay informed about the many scientific and administrative components that comprise ECOG-ACRIN's expectations for retaining membership in the Group. In addition, the evaluation ensures that member institutions maintain ECOG-ACRIN's high standards for conducting cancer research with and through the Group.
Data from the previous calendar year (2025) was evaluated. The following areas are part of the review: accrual, clinical data quality and timeliness, compliance with requirements for submission of laboratory samples and images, scientific leadership, administrative contribution, and compliance with policies of both ECOG-ACRIN and the National Cancer Institute (NCI) through its National Clinical Trials Network (NCTN) audit process. The review committee is blinded to the identity of the institutions during this initial evaluation when they give a numerical rating to these categories. However, final unblinded assessments are based on objective data and discussions on the unique aspects of each institution that cannot be captured in a numerical rating.
For 2026, the review committee voted to commend the following 35 networks and NCI Community Oncology Research Programs (NCORPs). Group Co-Chairs Peter J. O'Dwyer, MD, and Mitchell D. Schnall, MD, PhD, recognized them during the Fall 2026 Group Meeting General Session.
Overall Outstanding Performance
|
Institution |
Principal Investigator |
Administrator |
|
Aultman Health System/Timken Family Cancer Center |
Sunitha Vemulapalli, MD |
Mary Amos, RN, BSN |
|
Medical College of Wisconsin/MCW Cancer Center |
Mehdi H. Hamadani, MD |
Cassandra Gill, BA |
|
Metro Minnesota Community Oncology Research Consortium NCORP |
David M. King, MD |
Pamela Felix, RN |
|
The University of Texas/MD Anderson Cancer Center |
In Transition |
Shunte' Scott, MHA, BS |
|
University of Massachusetts/UMass Memorial Medical Center - University Campus |
Jan Cerny, MD, PhD |
Ashley Robichaud, RN, BSN |
|
University of Pennsylvania/Abramson Cancer Center |
Jennifer R. Eads, MD |
Kate S. Barbour, MS |
|
University of Washington/Fred Hutchinson Cancer Center |
Evan Y. Yu, MD |
Maggie So, MPH |
|
Washington University at St. Louis/Siteman Cancer Center |
Barry A. Siegel, MD |
Robin L. Haverman, BS |
Scientific Contribution and Lab Sample Submission
|
Institution |
Principal Investigator |
Administrator |
|
Mount Sinai Health System/The Tisch Cancer Institute |
Joseph A. Sparano, MD |
Shakira N. Forde, MS |
Scientific Contribution and Lab Sample and Imaging Submission
|
Institution |
Principal Investigator |
Administrator |
|
Montefiore Academic Community NCORP |
Balazs Halmos, MD |
Krysten Brown |
Scientific Contribution and Administrative Participation
|
Institution |
Principal Investigator |
Administrator |
|
Fox Chase Cancer Center |
Hossein Borghaei, DO |
Mary O'Rourke |
|
Johns Hopkins University/The Sidney Kimmel Comprehensive Cancer Center |
Julie R. Brahmer, MD |
Judy Murray, BS |
|
University of North Carolina at Chapel Hill/UNC Lineberger Comprehensive Cancer Center |
Siddharth Sheth, DO, MPH |
Jessica Huamani-Bundy, MS |
|
University of Wisconsin/UW Carbone Cancer Center |
Kari B. Wisinski, MD |
Jordan T. Nelson |
Scientific Contribution
|
Institution |
Principal Investigator |
Administrator |
|
Duke University/Duke Cancer Institute |
Daniel P. Barboriak, MD |
Phillip N. Jeffries, BS |
|
Memorial Sloan Kettering Cancer Center |
Eytan M. Stein, MD |
Edwin Zambrano-Acosta, MS |
|
University of California Irvine/Chao Family Comprehensive Cancer Center |
Ling Gao, MD, PhD |
Michelle Tran |
|
Yale University/Yale Cancer Center |
Barbara A. Burtness, MD |
Osarieme Oni, MS |
Administrative Participation
|
Institution |
Principal Investigator |
Administrator |
|
Thomas Jefferson University /Sidney Kimmel Comprehensive Cancer Center |
Steven J. Cohen, MD |
Pam Touchstone, BSN, MBA |
Accrual, Scientific Contribution, and Lab Sample Submission
|
Institution |
Principal Investigator |
Administrator |
|
Emory University/Winship Cancer Institute |
Michael C. Lowe, MD, MA |
Krystal Thomas, BS |
|
New York University/Laura and Isaac Perlmutter Cancer Center at NYU LangoneHealth |
Catherine S. Diefenbach, MD |
Melanie Huber, MPH |
Accrual, Scientific Contribution, and Administrative Participation
|
Institution |
Principal Investigator |
Administrator |
|
Northwestern University/Robert H. Lurie Comprehensive Cancer Center |
Al B. Benson III, MD |
Ericka Chant, MPH |
|
Rutgers Cancer Institute of New Jersey |
Neil D. Palmisiano, MD |
Cristina Jimenez-Ortigosa, PhD |
|
Stanford University/Stanford Cancer Institute |
Melinda L. Telli, MD |
Martina Steffen, MS |
|
Wisconsin NCORP |
Kurt R. Oettel, MD |
Mari K. Erickson, BA |
Accrual, Scientific Contribution, Administrative Participation, and Lab Sample Submission
|
Institution |
Principal Investigator |
Administrator |
|
The Ohio State University/The James Comprehensive Cancer Center |
James W. Rocco, MD, PhD |
Meghan Wyse, PhD |
Accrual, Scientific Contribution, Administrative Participation, and Imaging Submission
|
Institution |
Principal Investigator |
Administrator |
|
Harvard University/Dana-Farber/Harvard Cancer Center |
Frank S. Hodi, MD |
Nicole L. Hackett, MS |
|
Moffitt Cancer Center |
Jhanelle E. Gray, MD |
Victoria Kryliouk, DHSc, MSHS, CCRP |
Accrual and Scientific Contribution
|
Institution |
Principal Investigator |
Administrator |
|
Mayo Clinic Cancer Center |
Thomas M. Habermann, MD |
Mitchell Perrizo |
Accrual and Lab Sample and Imaging Submission
|
Institution |
Principal Investigator |
Administrator |
|
University of Oklahoma Health Sciences Center |
Jennifer L. Holter-Chakrabarty, MD |
Juanita Ortiz |
Accrual and Imaging
|
Institution |
Principal Investigator |
Administrator |
|
Aurora NCORP |
Thomas J. Saphner, MD |
Geraldine Lara |
Accrual
|
Institution |
Principal Investigator |
Administrator |
|
Case Western Reserve University |
Paolo F. Caimi, MD |
LaToya Strickland |
|
Mobile Infirmary Medical Center |
Furhan Yunus, BS, MD |
Alyssa Zediker |
|
University of Michigan/UM Comprehensive Cancer Center |
Thomas M. Enzler, MD, PhD |
Linda Charles |
|
The University of Texas Southwestern/Harold C. Simmons Comprehensive Cancer Center |
David E. Gerber, MD |
Erin Williams |
![ECOG-ACRIN logo[19516]275×75](https://blog.ecog-acrin.org/wp-content/uploads/2021/03/ECOG-ACRIN-logo19516275x75.png)
